1-hydroxy-3-amino-pyrrolidone-2 (HA-966). 3. Neurochemical aspects.
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D002252:Carbon Tetrachloride Poisoning; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004789:Enzyme Activation; D005971:Glutamates; D006498:Hepatectomy; D008099:Liver / Q000502:physiology; D008995:Monoamine Oxidase / Q000378:metabolism; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D011760:Pyrrolidinones / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D005971:Glutamates; D009125:Muscle Relaxants, Central; D011760:Pyrrolidinones; D012701:Serotonin; D008995:Monoamine Oxidase; D002262:Carboxy-Lyases; D004298:Dopamine; D009638:Norepinephrine